Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 68788-7527 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pregabalin caps 200mg 90s count

pregabalin caps 200mg 90s count

Figure 1 - pregabalin fig01

Figure 1 - pregabalin fig01

Figure 2 - pregabalin fig02

Figure 2 - pregabalin fig02

Figure 3 - pregabalin fig03

Figure 3 - pregabalin fig03

Figure 4 - pregabalin fig04

Figure 4 - pregabalin fig04

Figure 5 - pregabalin fig05

Figure 5 - pregabalin fig05

Figure 6 - pregabalin fig06

Figure 6 - pregabalin fig06

The text seems to be a table or a graph with different doses of medication (placebo, 50mg/day, 150mg/day, 300mg/day, and 600mg/day) for two studies (E1 and E3) being compared in terms of their statistical significance. Unfortunately, it does not provide further information as to the nature of the studies, or the specific outcome being measured.*

Figure 7 - pregabalin fig07

Figure 7 - pregabalin fig07

Figure 9 - pregabalin fig08

Figure 9 - pregabalin fig08

The text represents a graph showing the percentage of patients who experienced an improvement in pain from baseline when taking different doses of Pregabalin (300mg and 450mg) compared to a placebo. The X-axis shows the improvement in pain from baseline, while the Y-axis displays the different doses of Pregabalin and the placebo. It is not possible to analyze the graph without having access to the visual representation.*

Figure 10 - pregabalin fig09

Figure 10 - pregabalin fig09

The text appears to be a table showing estimated percentage of subjects without LTR for a drug called "Progabain" and a placebo over a period of up to 180 days. The percentages range from 0% to 100% at varying intervals.*

Figure 11 - pregabalin fig10

Figure 11 - pregabalin fig10

Figure 12 - pregabalin fig11

Figure 12 - pregabalin fig11

Percent of subjects improved data is provided in the text. It indicates the percent of improvement of the subjects from Bassine to Week 16. It also includes some garbled text.*

Cockcroft and Gault equation - pregabalin formula

Cockcroft and Gault equation - pregabalin formula

This appears to be a medical formula for calculating the CLCT (creatinine clearance) of a patient. The formula uses the patient's age in years and weight in kilograms, along with their serum creatinine level in milligrams per deciliter. The variable "mmmmmmmmm" is not readable, but it is likely a placeholder for a constant value that would be used in the calculation. For female patients, the result is multiplied by 0.85.*

Chemical Structure - pregabalin str

Chemical Structure - pregabalin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.